格隆汇2月11日丨富维股份(600742.SH)公布，2026年2月10日，公司第十一届董事会第十六次会议审议 通过《关于对一汽旗翼（深圳）科技有限公司增资项目实施的议案》，公司拟通过深圳联合产权交易所 以公开摘牌方式参与一汽旗翼增资（以下简称"本次增资"）。本次增资金额15,000万元，认购价格为不 高于按照经评估备案的净资产评估值33,273.70万元与2025年12月份实缴注册资本6,000万元的合计金额 确定。摘牌成功后，公司将与一汽旗翼及其他相关主体签署《增资协议》《一汽旗翼（深圳）科技有限 公司章程》等相关法律文本。 ...

格隆汇2月11日丨复旦微电(688385.SH)公布2026年限制性股票激励计划，本激励计划拟向激励对象授予 限制性股票1,388.00万股，约占本激励计划草案公告时公司总股本的1.69%。其中，首次授予限制性股 票1,116.00万股，约占本激励计划草案公告日公司总股本的1.35％，占本激励计划拟授予限制性股票总 额的80.40％；预留授予限制性股票272.00万股，约占本激励计划草案公告日公司总股本的0.33％，占本 激励计划拟授予限制性股票总额的19.60％。 截至本激励计划草案公告之日，全部有效期内股权激励计划所涉及的标的股票总额累计未超过本激励计 划草案公告日公司股本总额的10.00%。本激励计划中任何一名激励对象通过全部在有效期内的股权激 励计划获授的本公司股票累计未超过本激励计划提交股东会时公司股本总额的1.00%。 ...

控股股东、实际控制人的一致行动人江门市利和兴投资企业（有限合伙）（简称"利和兴投资"或"本企 业"）计划在本公告披露之日起15个交易日后的3个月内以集中竞价方式减持公司股份不超过127万股 （即不超过本公司总股本的0.5437%）。 格隆汇2月11日丨利和兴(301013.SZ)公布，控股股东、实际控制人的一致行动人黄禹岳先生计划在本公 告披露之日起15个交易日后的3个月内以集中竞价方式减持公司股份不超过106万股（即不超过本公司总 股本的0.4535%）。 ...

格隆汇2月11日丨东望时代(600052.SH)公布，公司拟以现金方式购买浙江科冠聚合物有限公司51%股 权。本次交易对方为野风集团有限公司、东阳市源泰实业投资合伙企业(有限合伙)、浙江野风创业投资 有限公司及东阳市野风控股有限公司，交易对价金额为1.94亿元，本次交易完成后，科冠聚合物将成为 公司控股子公司并纳入合并报表范围。 公司大股东东阳复创信息技术有限公司实际控制人俞蘠先生为本次交易对方野风集团、野风创投及野风 控股的实际控制人，为源泰实业的执行事务合伙人。根据《上海证券交易所股票上市规则》，本次交易 对方均为公司关联方，本次交易构成关联交易。截至本公告披露日，过去12个月内，公司下属子公司以 6万元的价款向野风集团下属子公司浙江野风名源房地产开发有限公司租赁车辆，为期一年。该交易与 本次交易合计金额达到3000万元以上，且占公司最近一期经审计净资产绝对值5%以上，本次关联交易 尚需提交公司股东会审议。 ...

Group 1 - The company announced the establishment of a joint venture, Hangzhou Huayu Thermal Control Technology Co., Ltd., to expand its liquid cooling business and enhance market competitiveness [1][2] - The registered capital of the joint venture is RMB 10 million, with the company's subsidiary contributing RMB 5.4 million (54% stake), while partners Yichen Youzan and Gaoshan Yuan contribute RMB 4.5 million (45%) and RMB 100,000 (1%) respectively [1] - This investment is a strategic move to leverage the trend of data center cooling technology upgrades and to build core capabilities in the industry [2] Group 2 - Liquid cooling technology is essential for achieving green and low-carbon data centers, ensuring stable operation and improving energy efficiency [2] - The company aims to integrate this key technology into its existing product matrix, enhancing its comprehensive solution capabilities in data centers and backup power systems [2] - This initiative signifies the company's ongoing strategy to strengthen its competitive edge in critical areas and improve customer value through more efficient and reliable infrastructure support [2]

Core Viewpoint - Feilu Co., Ltd. has terminated its stock issuance agreement with Shanghai Xiaoguang Intelligent Technology Co., Ltd. and the voting rights entrustment agreement with shareholder Zhang Weiguo, resulting in a significant change in control [1] Group 1 - The company signed a termination agreement with Xiaoguang Intelligent to end the stock issuance to specific targets [1] - The voting rights entrusted to Xiaoguang Intelligent will decrease from 18.71% to 5.02% following the termination of the agreement [1] - The company's controlling shareholder will revert from Xiaoguang Intelligent back to Zhang Weiguo, restoring him as the actual controller [1]

格隆汇2月11日丨飞鹿股份(300665.SZ)公布，自公司披露向特定对象发行股票事项以来，公司董事会、 管理层与中介机构等积极推进发行的各项工作，但截至目前尚未向深圳证券交易所提交申报材料。鉴于 外部环境及骁光智能自身情况发生较大变化，经骁光智能提出，公司与相关方充分沟通及协商后，决定 终止向特定对象发行股票事项并签署《解除协议》，且后续不会再向骁光智能发行股票。 ...

Core Viewpoint - Jincheng Pharmaceutical announced that its subsidiaries participated in the national centralized procurement for expiring drug agreements, with seven products, including Cefoperazone Sodium Injection and Ceftazidime Injection, expected to be selected for procurement [1] Group 1: Company Performance - The total sales revenue of the seven products expected to be selected for procurement in the first three quarters of 2025 is projected to be 414.46 million yuan, accounting for 21.45% of the company's total revenue during the same period [1] Group 2: Procurement Details - The procurement results are expected to be implemented by the end of March 2026, with the procurement cycle lasting until December 31, 2028 [1] - Medical institutions will prioritize the use of the selected drugs during the procurement cycle, ensuring the completion of the agreed procurement volume [1]

Core Viewpoint - Hars (002615.SZ) announced a restricted stock incentive plan for 2026, aiming to grant 3.6 million shares, which represents 0.77% of the company's total share capital of 466.267732 million shares as of the announcement date [1] Group 1 - The incentive plan involves a one-time grant with no reserved rights [1] - The recipients of the incentive plan include 5 individuals, specifically directors and senior management of the company [1] - The grant price for the restricted stock is set at 4.46 yuan per share [1]

Core Viewpoint - Perfect World announced that independent director Sun Ziqiang reduced his shareholding in the company by 44,300 shares at an average price of 22.38 yuan per share, representing 0.0023% of the total share capital [1] Summary by Relevant Sections - **Shareholding Reduction Details** - The reduction was executed through centralized bidding on February 10, 2026 [1] - Prior to the reduction, Sun Ziqiang held 177,200 shares, which accounted for 0.0091% of the total share capital [1] - After the reduction, his holdings decreased to 132,900 shares, representing 0.0069% of the total share capital [1] - The share reduction plan has been fully implemented [1]